To test this hypothesis, we generated NB cell lines in which the expression of RB1 was modulated using the CRISPRi technique and evaluated the cell behavior using cell biology assays and E2F-responsive luciferase vectors as a function of MYCN. This evidence concerns the gene RB1 and neuroblastoma.